Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Cutaneous Scleroderma”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Study completedNCT04647890
What this trial is testing

Effects of FT011 in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseSclerosis, Systemic
Certa Therapeutics 30
Not applicableEnded earlyNCT04244916
What this trial is testing

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 2
Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Ended earlyNCT04781543
What this trial is testing

Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 301
Post-approval studies (Phase 4)Ended earlyNCT03388255
What this trial is testing

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Who this might be right for
Scleroderma Disease
Mastelli S.r.l 25
Testing effectiveness (Phase 2)Study completedNCT00129428
What this trial is testing

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Who this might be right for
KeloidScleroderma, LocalizedAcne Keloidalis+2 more
University of Michigan 33
Not applicableLooking for participantsNCT07256418
What this trial is testing

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Who this might be right for
Scleroderma
Centre Hospitalier Universitaire Dijon 60
Testing effectiveness (Phase 2)Study completedNCT03708718
What this trial is testing

Prednisolone in Early Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Prof. Ariane herrick 35
Not applicableLooking for participantsNCT07090226
What this trial is testing

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Who this might be right for
Systemic SclerodermaDiffuse Cutaneous Scleroderma
Boston University 65
Not applicableStudy completedNCT01093885
What this trial is testing

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Who this might be right for
Systemic SclerosisScleroderma
University of Pennsylvania 15
Not applicableEnded earlyNCT00476697
What this trial is testing

UVA1 Light for Scleroderma and Similar Conditions

Who this might be right for
KeloidSclerodermaScars+2 more
University of Michigan 23
Testing effectiveness (Phase 2)Study completedNCT01538719
What this trial is testing

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisDiffuse Scleroderma+1 more
Boston University 24
Early research (Phase 1)Not Yet RecruitingNCT07439029
What this trial is testing

YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Diffuse Systemic SclerosisIdiopathic Inflammatory Myopathies (IIMs)+3 more
Children's Hospital of Fudan University 12
Testing effectiveness (Phase 2)Ended earlyNCT04680975
What this trial is testing

Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 10
Early research (Phase 1)Study completedNCT01284322
What this trial is testing

Fresolimumab In Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Boston University 18
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Testing effectiveness (Phase 2)Ended earlyNCT02465437
What this trial is testing

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 42
Not applicableLooking for participantsNCT06387654
What this trial is testing

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Who this might be right for
Autoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases+1 more
University Hospital, Toulouse 800
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Load More Results